G&E Herbal Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2018
November 08, 2018 at 12:54 pm EST
Share
G&E Herbal Biotechnology Co., Ltd. announced earnings results for the third quarter ended September 30, 2018. For the third quarter, the company announced sales was TWD 425,000 compared to TWD 1.949 million a year ago. Operating loss was TWD 7.743 million compared to TWD 9.055 million a year ago. Net loss was TWD 4.696 million compared to TWD 14.082 million a year ago. Basic earnings per share was TWD 0.09 compared to TWD 0.25 a year ago. For the nine months, sales was TWD 541,000 compared to TWD 19.876 million a year ago. Operating loss was TWD 29.105 million compared to TWD 24.366 million a year ago. Net loss was TWD 16.037 million compared to TWD 24.663 million a year ago. Basic earnings per share was TWD 0.29 compared to TWD 0.44 a year ago.
G&E Herbal Biotechnology Co., Ltd is a Taiwan-based company principally engaged in the research and development, manufacture and distribution of health care food products, functional skin care products and pharmaceutical products. Its health care food products include accessory food products and capsules for cancer and urogenital disorder. The Company also provides botanical medicines for cancers and liver diseases. The Company distributes its products within domestic market and to overseas markets.
G&E HERBAL BIOTECHNOLOGY CO., LTD. 
